Clinical and Experimental Ophthalmology

Papers
(The TQCC of Clinical and Experimental Ophthalmology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Past Lecturers and Briefs For the Named Lectures: RANZCO Annual Scientific Congress205
Continuing Professional Development96
Issue Information83
Issue Information68
Proposal of a Simpler Eye‐Level Risk Model Incorporating Reticular Pseudodrusen for the Clinical Prediction of Late Age‐Related Macular Degeneration55
Vaccination with circulating exosomes in autoimmune uveitis prevents recurrent intraocular inflammation54
Role of chloramphenicol eye drops for endophthalmitis prophylaxis following cataract surgery: Outcomes of institutional cessation54
Improved methods for isolating the mouse retinal vasculature51
Circular RNA expression profile and functional analysis of circUvrag in light‐induced photoreceptor degeneration46
Recent advances in the use of optical coherence tomography in neuro‐ophthalmology: A review43
Fluid misdirection syndrome associated with endothelial keratoplasty: A multicenter case series39
Microbiological diagnosis of endophthalmitis using nanopore targeted sequencing37
Genetics in neovascular age‐related macular degeneration susceptibility and treatment response to anti‐VEGF intravitreal injection: A case series study37
Mimickers of hydroxychloroquine retinal toxicity36
Telemedicine and delivery of ophthalmic care in rural and remote communities: Drawing from Australian experience32
The association between keratoconus and allergic eye diseases: A systematic review and meta‐analysis29
Continuing Professional Development28
Continuing Professional Development26
Issue Information24
Sunday 27 February Speakers23
21
Continuing Professional Development20
Bevacizumab biosimilar (bevacizumab‐awwb) is safe in the treatment of retinopathy of prematurity20
20
Issue Information20
Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration in 2022: Same, same but different19
Management of macular oedema due to retinal vein occlusion: An evidence‐based systematic review and meta‐analysis18
Is it time to consider how we approach bilateral same‐day cataract surgery?18
Social determinants of health and health disparities in glaucoma: A review18
Comparison of various treatment modalities in patients with primary vitreoretinal lymphoma: A systematic review and meta‐analysis18
Gender differences in retinal diseases: A review18
Global challenges in the management of diabetic retinopathy in women with pre‐gestational diabetes18
17
Optimised minus lens overcorrection for paediatric intermittent exotropia: A randomised clinical trial17
‘Closing the gap’ on visual acuity outcomes of Indigenous and remote patients receiving intravitreal injections in Northern Australia17
Publishing opportunities and gender equity: Embedding monitoring in eye health education17
16
Suprachoroidal steroids for uveitic macular oedema: Teaching an old drug new tricks?16
Corneal endothelial evaluations in immunoglobulin g4‐related ophthalmic disease16
Issue Information16
Environmental influences on ophthalmic conditions: A scoping review16
Issue Information16
Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerances15
Seasonal Variation in HLAB27 Associated Uveitis15
Randomised controlled trial on robot‐assisted versus manual surgery for pucker peeling15
Optimising the Evaluation of Optic Neuritis YouTube Videos: A Call for Multimedia‐Specific Tools and Audience‐Oriented Approaches—Response15
Topical Dorzolamide for Macular Holes: A Randomised, Double‐Blind, Placebo‐Controlled Trial–Comment14
Comparison of metabolic profiles in aqueous humour of Fuchs' syndrome and presumed viral‐induced anterior uveitis patients14
Chronic Kidney Disease and Glaucoma: Is the Case Truly Closed?14
Seasonal Trends in HLAB27‐Associated Uveitis: A Commentary on Recent Findings13
Bridging healthcare disparities in diabetic retinopathy care: Insights from Sri Lanka13
Long‐term limitations and complications of trans‐scleral diode laser cycloablation for refractory glaucoma13
Comparative study of 2‐year outcomes for Hydrus or iStent inject microinvasive glaucoma surgery implants with cataract surgery12
Corrigendum12
Myopia progression following 0.01% atropine cessation in Australian children: Findings from the Western Australia – Atropine for the Treatment of Myopia (WA‐ATOM) study12
Monday 28 February Speakers12
Evaluation of ChatGPT‐4 responses to glaucoma patients' questions: Can artificial intelligence become a trusted advisor between doctor and patient?12
EDITORIAL PROFILES12
Keratoconus in Down syndrome: Prevalence, risk factors, severity and corneal tomographic characteristics11
Scientific Program11
Dr AI will see you now11
Leber Hereditary Optic Neuropathy: Support, Genetic Prediction and Accurate Genetic Counselling Enhance Family Planning Choices11
Antimicrobial stewardship in ocular infections: Fourteen years of over‐the‐counter chloramphenicol in Australia11
11
Biometry and corneal aberrations after cataract surgery in childhood11
Insights into the diagnosis and management of sarcoid uveitis: A review11
Central serous chorioretinopathy: A review10
Correction to ‘Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerance’10
Saturday 02 November10
Predictive Factors for Uveitis Refractory to Treatment in Initial‐Onset Acute Vogt‐Koyanagi‐Harada Disease10
Australian Pharmaceutical Benefits scheme data on utilisation of intravitreal therapy in retinal vein occlusion10
Issue Information10
Retraction10
Are There Biomechanical Changes in Tomographically Progressive Keratoconus Corneas?10
Continuing Professional Development10
AI: From productivity dividend to better patient outcome9
Saturday 29 October Speakers9
Diagnostic Ability of Transverse Axial Images Obtained by Optical Coherence Tomography for Detecting Anterior Displacement of Peripapillary Tissues in Papilledema9
Issue Information9
Investigation of epidemiological characteristics and development of a nomogram to predict survival in primary ocular adnexal lymphoma9
Outcomes of Stent Removal in Eyes With the Paul Glaucoma Implant With Intraluminal 6–0 Polypropylene9
Te hauora karu o te iwi Māori: A comprehensive review of Māori eye health in Aotearoa/New Zealand9
Longitudinal Visual Biomarkers in Dominant Optic Atrophy: A Systematic Review and Meta‐Analysis8
Epidemiology of monocanalicular stenting in paediatric lacrimal canalicular trauma8
Utility of topical cocaine testing for the evaluation of paediatric anisocoria8
Biomarkers in age‐related macular degeneration8
Evaluation of ocular surface following PreserFlo Microshunt implantation: Functional outcomes and quality of life8
Outcomes of cataract surgery in paediatric uveitis: A multisite study8
Retreatment interval lengthening achieved in two thirds of eyes with prolonged intensive anti‐VEGF therapy for neovascular age‐related macular degeneration after switching to faricimab8
Issue Information8
Evaluation of mild periorbital cellulitis and home‐based therapy in children—EPOCH study: A prospective single centre cohort study8
Nocturnal hypoxia and age‐related macular degeneration8
Evaluation of artificial intelligence models for the detection of asymmetric keratoconus eyes using Scheimpflug tomography7
Current understanding of subclinical diabetic retinopathy informed by histology and high‐resolution in vivo imaging7
Detecting Glaucoma in Highly Myopic Eyes From Fundus Photographs Using Deep Convolutional Neural Networks7
Issue Information7
Evaluation of moderate periorbital cellulitis and home‐based therapy in children (EPOCH study, Part 2): A prospective single centre cohort study7
Eyes Offshore: Reporting the Eye Health Needs of Refugees and Asylum Seekers in Australia's Offshore Detention Centres7
Utilisation of Genetic Testing of Inherited Retinal Diseases in an Australian Public Tertiary Hospital Setting7
Retinal Gene Therapy: Perceptions of Ophthalmologists in Australia and New Zealand7
Global retinoblastoma studies: A review6
Poster Abstracts6
Seeking best outcomes for patients living with vitreoretinal lymphoma6
Continuing Professional Development6
Safety of an Intravitreal Bevacizumab Biosimilar (MVASI)6
Impact of glucagon‐like peptide‐1 receptor agonists on diabetic retinopathy: A meta‐analysis of clinical studies emphasising retinal changes as a primary outcome6
Reliability of surgical memory and self‐report in patients with prior strabismus surgery6
Normal‐tension glaucoma: Current concepts and approaches‐A review6
Continuing professional development6
A retinal endothelial cell barrier is disrupted by direct contact with retinal Müller glial cells in vitro6
Natural history and biomarkers of KCNV2‐associated retinopathy6
Prediction of refraction error after toric lens implantation with biometric input data uncertainties and power labelling tolerances: Response5
The enigma of corneal astigmatism5
Optic nerve sheath fenestration for treating papilloedema in the era of cerebral venous sinus stenting5
Quality of eye care: Time to act5
Continuing Professional Development5
A focus on glaucoma5
Issue Information5
Ageing and retinal thickness: An important association5
Predictability of success for combined iStent inject trabecular bypass implantation with phacoemulsification in the subsequent eye5
Therapeutic prognostic factors associated with retinal detachment and visual outcomes in acute retinal necrosis5
Topical dorzolamide for macular holes: A randomised, double‐blind, placebo‐controlled trial5
Effect of lens status and age on ultra‐wide‐field fundus autofluorescence in eyes with granular corneal dystrophy5
Medical therapy for glaucoma: A review5
Past Lecturers and Briefs for the Named Lectures: RANZCO Annual Scientific Congress5
Real‐world outcomes of low‐dose atropine therapy on myopia progression in an Australian cohort during the COVID‐19 pandemic5
Powerful predictors5
Continuing Professional Development5
Diabetic Retinopathy During Pregnancy: Implications of Intensive Control Prior to Pregnancy With Incretin Mimetic Therapy in Type 2 Diabetes Mellitus5
One‐year real‐world outcomes of bevacizumab for the treatment of macular oedema secondary to retinal vein occlusion5
The Challenge of Managing Paediatric Periorbital Cellulitis5
Running to save sight: The effects of exercise on retinal health and function5
Reactivation of stable neovascular age‐related macular degeneration following treat‐and‐extend regimen discontinuation5
An old yet new issue: Infection of the eye5
CONTINUING PROFESSIONAL DEVELOPMENT5
5
Low‐concentration atropine eyedrops for myopia control in a multi‐racial cohort of Australian children: A randomised clinical trial5
Comparison of intraocular pressure and anterior segment parameters in subjects with asymmetrical primary angle closure disease5
Film Abstracts5
Invited Speakers4
Association of obesity and metabolic syndrome with incident primary open angle glaucoma in the UK Biobank4
Deep learning in optical coherence tomography: Where are the gaps?4
Uveitis masquerade syndromes: An approach to diagnosis4
Should this artificial intelligence algorithm be used in my practice now? A checklist approach: Response4
Continuing professional development4
Visual fields in glaucoma: Where are we now?4
Use of antihypertensive medications and the risk of glaucoma onset: Findings from the 45 and Up Study4
Efficacy of oral doxycycline in the treatment of recurrent corneal erosion syndrome4
Sustained and rebound effect of repeated low‐level red‐light therapy on myopia control: A 2‐year post‐trial follow‐up study4
Preclinical biocompatibility and biosafety evaluation of a new foldable brown diaphragm intraocular lens: An in vitro and in vivo study4
Utilisation of patient‐centred outcome measures in age‐related macular degeneration research and clinical practice: A systematic review4
The Royal Australian and New Zealand College of Ophthalmologists, 55th Annual Scientific Congress 1 – 4 November 2024Adelaide Convention Centre4
Risk factors associated with XEN gel stent‐related endophthalmitis4
4
Evidence on the Use of Topical Ciclosporin for Ocular Surface Disease: A Systematic Review and Meta‐Analysis—Response4
Retention time of different ophthalmic viscosurgical devices during phacoemulsification in rabbit ocular model: A comparative analysis4
4
Film Abstracts4
Continuing Professional Development4
Assessing the carbon footprint of fluorinated gases in vitreoretinal surgery4
A novel genomic rearrangement on chr19q13.42 leads to PRPF31‐associated retinitis pigmentosa4
Invited Speakers4
Retinal neural dysfunction in diabetes revealed with handheld chromatic pupillometry4
The challenge in the diagnosis and management of vitreoretinal lymphoma4
Association between dietary niacin and retinal nerve fibre layer thickness in healthy eyes of different ages4
Issue Information4
0.22504901885986